InvestorsHub Logo
Followers 50
Posts 5075
Boards Moderated 0
Alias Born 03/23/2014

Re: betweenthelines post# 15767

Monday, 07/21/2014 3:34:31 PM

Monday, July 21, 2014 3:34:31 PM

Post# of 732210

I believe it will be the next important PR, so just trying to figure out when it may be coming.



I have been hoping that NWBio would provide a PR update on this for some time now. The PR seemed to indicate that they might negotiate reimbursement rates & terms within months .... so in my mind it could have been as soon as May 2014.

Here is the March 10th PR:
http://www.nwbio.com/nw-bio-announces-two-german-approvals-hospital-exemption-for-early-access-program-with-dcvax-l-and-eligibility-of-dcvax-l-for-reimbursement/

As you will note, it includes:

The amount and terms for such reimbursement will now be negotiated by NW Bio, the hospitals and the Sickness Funds over the coming months, and will be applied to patients case by case. In the meantime, patients may self-pay for DCVax-L.



and

DCVax-L will be administered under the Hospital Exemption as an adjuvant treatment after surgical removal of the tumor and radiation/chemotherapy where applicable. The Company will provide annual data reports to the German regulatory authority during the five-year term of the Hospital Exemption.

The Company expects to activate this program over the coming months.



So: if NWBio was to "activate the program over the coming months" (since March 2014) ..... I was expecting NWBio to post an update (PR) by now.
My Google searches for any news of anyone being treated under this program have not produced any results. Neither have my google search for any update on reimbursement.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News